Emory Research Administration News

Tag: NIH

  • New Update: NIH Guidelines for working with AAV and rAAV vectors

    —

    by

    Beth Savoy
    in

    NEW UPDATE: NIH Guidelines The “Guidelines for working with replication-incompetent Adeno-Associated (AAV), recombinant AdenoAssociated (rAAV), Lentivirus and Adeno viral vectors in lab and animal research” have been updated to reflect current NIH/OBA guidance. What was the change in the NIH Guide? Appendix B-1 assessed AAV and rAAV as Risk Group 1 (RG1) agents. RG1 agents are…

  • Upcoming National Institutes of Health (NIH) Site Visit

    —

    by

    Beth Savoy
    in

    The National Institutes of Health (NIH) Office of Biotechnology Activities (OBA) will conduct a site visit at Emory’s main campus on March 18th, 2014.  During the site visit, the team will review and evaluate the Institution’s compliance with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules.  The site visit will primarily…

  • Upcoming National Institutes of Health (NIH) Site Visit

    —

    by

    Beth Savoy
    in

    The National Institutes of Health (NIH) Office of Biotechnology Activities (OBA) will conduct a site visit at Emory’s main campus on March 18th, 2014.  During the site visit, the team will review and evaluate the institution’s compliance with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules.  The site visit will primarily…

  • NIH Public Access Policy Reminders

    —

    by

    Demetrice S. Bryant
    in

    As NIH moves toward enhanced enforcement of their Public Access Policy, please bear in mind these important reminders. Applicability The policy applies to all peer-reviewed articles that arise, in whole or in part, from direct costs funded by NIH that are accepted for publication on or after April 7, 2008. Publications that are accepted for…

  • Recent Biosafety Protocol & Regulation Changes

    —

    by

    Beth Savoy
    in

    Recent changes were made the NIH Office of Biotechnology to the NIH Guidelines for Research Involving Recombinant and Synthetic Nucleic Acid Molecules. Also, changes were made to Biosafety Protocol review process including the committee structure. These changes have been reflected in a Change Summary document that is posted on the EHSO website: http://www.ehso.emory.edu/programs/research/research-protocol.cfm Please review…

  • Changes to the NIH Guidelines & Biosafety Training

    —

    by

    Beth Savoy
    in

    On September 12th, 2012, the National Institutes of Health (NIH) published a revision to the NIH Guidelines that will go into effect on March 5th, 2013. The most significant change to the Guidelines was the incorporation of research involving synthetic nucleic acid molecules. Due to the inclusion of these experiments to the document, the NIH…